UCSF’s innovative, collaborative approach to patient care, research and education spans disciplines across the life sciences, making it a world leader in scientific discovery and its translation to improving health.
Dr. Suzee Lee is a Professor of Neurology, the Director of the Dementia Imaging Genetics Lab, and the Director of the Visiting Scholars Program at the UCSF Weill Institute of Neuroscience’s Memory and Aging Center. Dr. Lee is a behavioral neurologist who received a BA degree in English and American Literature and Language from Harvard College and an MD degree from the McGill Faculty of Medicine.
Dr. Geschwind received his MD and PhD degrees in neuroscience through the National Institutes of Health (NIH)-sponsored Medical Scientist Training Program (MSTP) at the Albert Einstein College of Medicine in New York. He completed his internship in internal medicine at the University of California, Los Angeles (UCLA) Medical Center, his neurology residency at the Johns Hopkins University School of Medicine in Baltimore and his fellowship in behavioral neurology at the UCSF Memory and Aging Center (MAC). He is a Professor of Neurology at the MAC.
Dr. Watson graduated from the Pacific Graduate School of Psychology-Stanford PsyD Consortium in 2014. She has a background in psychology, developmental biology, neuroimaging and neuropsychology. Her research interests include brain development across the lifespan and, in particular, in the neuroscience of typical and atypical learning. She is currently working in the ALBA Language Neurobiology Lab with Dr. Maria Luisa Gorno Tempini.
Virginia Sturm, PhD, is the John Douglas French Alzheimer’s Foundation Endowed Professor at UCSF. She is a Professor in the Departments of Neurology and Psychiatry and Behavioral Sciences, and she is the director of the Clinical Affective Neuroscience (CAN) Laboratory that is located in the UCSF Memory and Aging Center and affiliated with the UCSF Center for Psychophysiology and Behavior (CPB).
Dr. Seeley attended medical school at the University of California, San Francisco (UCSF) School of Medicine, where he first encountered patients with frontotemporal dementia (FTD) in 1999, during a research elective with Dr. Bruce Miller. He completed a neurology residency at Harvard Medical School, training at the Massachusetts General and Brigham & Women's Hospitals. Returning to UCSF for a Behavioral Neurology fellowship, Dr.
Dr. Valcour is a Professor of Medicine with a shared appointment in the Division of Geriatric Medicine and the Department of Neurology. His work crosses disciplines to research and care for cognitive disorders in aging populations and to understand brain injury in the setting of HIV among all ages, including funded pediatric HIV studies. His clinical work involves consultations for patients with cognitive disorders at the UCSF Memory and Aging Center.
Dr. Rosen is a behavioral neurologist and holds the Dorothy Kirsten French Foundation Endowed Professorship for Parkinsonian and Other Neurodegenerative Disorders. He received his medical degree from Boston University School of Medicine, trained in internal medicine at the Albert Einstein College of Medicine in New York, and subsequently completed a neurology residency at UCSF. After residency, Dr. Rosen pursued fellowship training in brain imaging at the Washington University School of Medicine, and then returned to UCSF to join the team at the Memory and Aging Center (MAC) in 1999.
Dr. Kramer is a Professor of Neuropsychology in Neurology, the Director of the Memory and Aging Center Neuropsychology program, and the John Douglas French Alzheimer’s Foundation Endowed Professor at UCSF. He earned his doctorate in psychology at Baylor University and completed a postdoctoral fellowship in neuropsychology at the Martinez VA hospital. Dr. Kramer is board certified in clinical neuropsychology.
Bruce L. Miller, MD, holds the A.W. and Mary Margaret Clausen Distinguished Professorship in Neurology at the University of California, San Francisco, directs the UCSF Memory and Aging Center and is the founding director of the Global Brain Health Institute at UCSF. In addition, he helps lead the Tau Consortium and The Bluefield Foundation, precision medicine collaborations focused on developing treatments for tauopathies and progranulin-mediated forms of frontotemporal dementia.